home | publications

2008 PUBLICATIONS

1. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer
Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG, Dobi A, Srivastava S, Petrovics G, Sesterhenn IA.
Mod Pathol. 2008 Feb;21(2):67-75. Epub 2007 Dec 7.
Abstract

2. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells
Li H, Zhou J, Miki J, Furusato B, Gu Y, Srivastava S, McLeod DG, Vogel JC, Rhim JS.
Exp Cell Res. 2008 Jan 1;314(1):92-102. Epub 2007 Aug 23.
Abstract

3. Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
Sterbis JR, Gao C, Furusato B, Chen Y, Shaheduzzaman S, Ravindranath L, Osborn DJ, Rosner IL, Dobi A, McLeod DG, Sesterhenn IA, Srivastava S, Cullen J, Petrovics G.
Clin Cancer Res. 2008 Feb 1;14(3):758-63.
Abstract

4. SELDI-TOF MS Whole Serum Proteomic Profiling With IMAC Surface Does Not Reliably Detect Prostate Cancer
McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, Sokoll L, Srivastava S, Srivastava S, Thornquist M, Troyer D, Wright GL, Zhang Z, Zhu L, Semmes
OJ: Clin Chem. 2008 Jan;54(1):53-60. Epub 2007 Nov 16. Links.
Abstract

5. Analytical Validation Of Serum Proteomic Profiling For Diagnosis Of Prostate Cancer: Sources Of Sample Bias
McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ.
Clin Chem. 2008 Jan; 54(1):44-52. Epub 2007 Nov 2.
Abstract

6. TMPRSS2-ERG Fusion, A Common Genomic Alteration In Prostate Cancer Activates C-MYC And Abrogates Prostate Epithelial Differentiation
Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, Shaheduzzaman S, Tan SH, Vaidyanathan G, Whitman E, Hawksworth DJ, Chen Y, Nau M, Patel V, Vahey M, Gutkind JS, Sreenath T, Petrovics G, Sesterhenn IA, McLeod DG, Srivastava S.
Oncogene. 2008 Jun 9. [Epub ahead of print]
Abstract

7. Prostate Cell Cultures As In Vitro Models For The Study Of Normal Stem Cells And Cancer Stem Cells
Miki J, Rhim JS.
Prostate Cancer Prostatic Dis. 2008;11(1):32-9. Epub 2007 Nov 6.
Abstract

8. Early Versus Delayed Hormonal Therapy For Prostate Specific Antigen Only Recurrence Of Prostate Cancer After Radical Prostatectomy
Moul JW, Wu H, Sun L, McLeod DG, Amling C, Donahue T, Kusuda L, Sexton W, O'Reilly K, Hernandez J, Chung A, Soderdahl D.
J Urol. 2008 May;179(5 Suppl):S53-9.
Abstract

9. Do Patients With Low Volume Prostate Cancer Have PSA Recurrence Following Radical Prostatectomy?
Furusato B, Rosner IL, Osborn D, Ali A, Srivastava S, Davis CJ, Sesterhenn IA, McLeod DG.
J Clin Pathol. 2008 Jun 13. [Epub ahead of print]
Abstract

10. Editorial Comment On: New Treatment Approaches For Prostate Cancer Based On Peptide Analogues
McLeod DG.
Eur Urol. 2008 May;53(5):898-9. Epub 2007 Dec 26.
Abstract

11. Expression Of The TMPRSS2: ERG Fusion Gene Predicts Cancer Recurrence After Surgery For Localised Prostate Cancer
Nam RK, Sugar L, Yang W, Srivastava S, Klotz LH, Yang LY, Stanimirovic A, Encioiu E, Neill M, Loblaw DA, Trachtenberg J, Narod SA, Seth A.
Br J Cancer. 2007 Dec 17;97(12):1690-5. Epub 2007 Oct 30.
Abstract

12. Transcriptome Analysis of benign and malignant prostate epithelial cells in formalin fixed paraffin-embedded, whole–mounted radical prostatectomy specimens
Furusato B, Shaheduzzaman S, Petrovics S, Dobi A, Seifert M, Ravindranath L, Nau ME, Werner T, Vahey M, McLeod DG,
Srivastava S, Sesterhenn, IA.
Prostate Cancer Prostate Dis. 11: 194-197, 2008

13. Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
Hu Y, Dobi A, Sreenath T, Cook C, Tadese AY, Ravindranath L, Cullen J, Furusato B, Chen Y, Thangapazham R, Mohamed A, Sun C, Sesterhenn IA,
McLeod DG, Petrovics G, Srivastava S.
Clinical Cancer Res. 2008 (in press).

14. Androgen Responsive and Refractory Prostate Cancer Cells Exhibit Distinct Curcumin Regulated Transcriptome
Thangapazham R.L., Shaheduzzaman S.,
Kim K-H., Passi N., Vahey M., Dobi A., Srivastava S., K. Maheshwari R.
Cancer Biology and Therapy 2008 (in press).

15. PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor
Whitman EJ, Groskopf J, Ali A, Chen Y, Blasé A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG.
Journal of Urology, 2008 (in press)

16. Androgen Responsive and Refractory Prostate Cancer Cells Exhibit Distinct Curcumin Regulated Transcriptome
Thangapazham RL, Shaheduzzaman S, Kim K-H, Passi N, Vahey M, Dobi A, Srivastava S, Maheshwari R
Cancer Biology and Therapy, 2008 (in press).

17. A Feedback Loop Between the Androgen Receptor and a NEDD4 Binding Protein, PMEPA1 in Prostate Cancer Cells
Li H, Xu LL, Masuda K, Raymundo E, McLeod DG, Dobi A, Srivastava S
J Biol Chem. 2008 Aug 14. [Epub ahead of print]
Abstract